JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
JUPITER NEUROSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$2.75−0.15 (-5.34%)
Close on Oct 19, 2026
- Market cap
- $1.53M
- P/E (TTM)
- –
- Dividend yield
- –
Jupiter Neurosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Market Cap | $2.12M | $164.85M |
| Enterprise Value | $595.85K | $87.06M |
Income (trailing twelve months)
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Operating Income | -$9.81M | -$21.44M |
| Net Income | -$9.20M | -$22.46M |
| EBITDA | -$9.81M | -$16.91M |
| EPS (Diluted) | -$18.89 | -$0.83 |
Returns
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -1888.7% | -53.1% |
| Return on Assets (ROA) | -239.4% | -41.0% |
Balance sheet
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.52M | $62.42M |
| Net Cash (Debt) | $1.52M | $15.68M |
| Net Cash Per Share | $1.98 | $0.66 |
| Equity (Book Value) | -$365.97K | $48.79M |
| Book Value Per Share | -$0.48 | $1.36 |
| Tangible Book Value | -$365.97K | $23.06M |
| Working Capital | -$1.33M | $75.77M |
Financial position
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Current Ratio | 0.66 | 3.30 |
| Quick Ratio | 0.39 | 2.39 |
| Interest Coverage | -35.95 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.25M | -$12.35M |
Efficiency
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$1.84M | -$703.34K |
| Employee Count | 5 | 74 |
Dividends and yields
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Earnings Yield | -434.4% | -22.7% |
Shares
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Shares Outstanding | 770,081 | 58,179,650 |
| Shares Change (YoY) | 15.7% | 11.1% |
| Shares Change (QoQ) | 37.4% | 0.54% |
Scores
| Measure | Jupiter Neurosciences | Industry median |
|---|---|---|
| Altman Z-Score | -23.51 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Jupiter Neurosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.